IL186307A0 - Human glp-1 mimetibodies, compositions, methods and uses - Google Patents

Human glp-1 mimetibodies, compositions, methods and uses

Info

Publication number: IL186307A0
Authority: IL; Israel
Prior art keywords: mimetibodies; compositions; methods; human glp; glp
Prior art date: 2005-03-28

Application number

IL186307A

Original Assignee

Centocor Ortho Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-28

Filing date

2007-09-25

Publication date

2008-01-20

2007-09-25 Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc

2008-01-20 Publication of IL186307A0 publication Critical patent/IL186307A0/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2318/00—Antibody mimetics or scaffolds
- C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes

IL186307A 2005-03-28 2007-09-25 Human glp-1 mimetibodies, compositions, methods and uses IL186307A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2005097175		2005-03-28
PCT/US2005/046884 WO2007081302A2 (en)	2005-03-28	2005-12-22	Human glp-1 mimetibodies, compositions, methods and uses

Publications (1)

Publication Number	Publication Date
IL186307A0 true IL186307A0 (en)	2008-01-20

Family

ID=38256744

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL186307A IL186307A0 (en)	2005-03-28	2007-09-25	Human glp-1 mimetibodies, compositions, methods and uses

Country Status (12)

Country	Link
EP (1)	EP1871811A4 (en)
JP (1)	JP2008546373A (en)
KR (1)	KR20080005378A (en)
CN (1)	CN101389346A (en)
AU (1)	AU2005339797A1 (en)
BR (1)	BRPI0520168A2 (en)
CA (1)	CA2603359A1 (en)
CR (1)	CR9481A (en)
IL (1)	IL186307A0 (en)
MX (1)	MX2007011975A (en)
NO (1)	NO20075272L (en)
WO (1)	WO2007081302A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UY30820A1 (en) *	2006-12-21	2008-07-03	Centocor Inc	USE OF LONG-TERM ACTION GLP-1 RECEPTOR AGONISTS TO IMPROVE INSULIN SENSITIVITY AND LIPID PROFILES
CN111574583B (en) *	2020-04-10	2021-06-25	上海海路生物技术有限公司	Protein renaturation reagent and its application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3224700A (en) *	1999-02-08	2000-08-25	Chiron Corporation	Fibroblast growth factor receptor-immunoglobulin fusion
WO2002046227A2 (en) *	2000-12-07	2002-06-13	Eli Lilly And Company	Glp-1 fusion proteins
US7241733B2 (en) *	2002-06-28	2007-07-10	Centocor, Inc.	Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
AU2003280130B2 (en) *	2002-06-28	2009-06-11	Centocor, Inc.	Mammalian CH1 deleted mimetibodies, compositions, methods and uses
CA2531482A1 (en) *	2003-06-30	2005-01-20	Centocor, Inc.	Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
CA2563379A1 (en) *	2004-03-31	2005-10-20	Centocor, Inc.	Human glp-1 mimetibodies, compositions, methods and uses

2005
- 2005-12-22 BR BRPI0520168-3A patent/BRPI0520168A2/en not_active Application Discontinuation
- 2005-12-22 MX MX2007011975A patent/MX2007011975A/en not_active Application Discontinuation
- 2005-12-22 WO PCT/US2005/046884 patent/WO2007081302A2/en active Application Filing
- 2005-12-22 KR KR1020077024874A patent/KR20080005378A/en not_active Application Discontinuation
- 2005-12-22 CN CNA200580049931XA patent/CN101389346A/en active Pending
- 2005-12-22 AU AU2005339797A patent/AU2005339797A1/en not_active Abandoned
- 2005-12-22 JP JP2008504018A patent/JP2008546373A/en active Pending
- 2005-12-22 CA CA002603359A patent/CA2603359A1/en not_active Abandoned
- 2005-12-22 EP EP05858723A patent/EP1871811A4/en not_active Withdrawn
2007
- 2007-09-25 IL IL186307A patent/IL186307A0/en unknown
- 2007-10-15 NO NO20075272A patent/NO20075272L/en not_active Application Discontinuation
- 2007-10-29 CR CR9481A patent/CR9481A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
BRPI0520168A2 (en)	2009-04-22
MX2007011975A (en)	2008-03-14
NO20075272L (en)	2007-12-28
WO2007081302A2 (en)	2007-07-19
AU2005339797A1 (en)	2007-07-19
EP1871811A4 (en)	2009-07-22
KR20080005378A (en)	2008-01-11
CA2603359A1 (en)	2007-07-19
CN101389346A (en)	2009-03-18
CR9481A (en)	2009-01-14
EP1871811A2 (en)	2008-01-02
JP2008546373A (en)	2008-12-25
WO2007081302A3 (en)	2008-11-13

Publication	Publication Date	Title
ZA200709266B (en)	2009-05-27	Human GLP-1 mimetibodies, compositions, methods and uses
HUS1800021I1 (en)	2018-06-28	Human anti-il-23 antibodies, compositions, methods and uses
ZA200901132B (en)	2010-10-27	Human GLP-1 mimetibodies, compositions, methods and uses
HK1209729A1 (en)	2016-04-08	Compounds, compositions and methods
IL209494A (en)	2015-07-30	Insulin-oligomer monoconjugates, formulations and uses thereof
IL183940A0 (en)	2007-10-31	Glp-1 agonists, compositions, methods and uses
IL191655A0 (en)	2008-12-29	Novel compounds, their preparation and use
EP1895838A4 (en)	2013-03-06	Compositions and methods
IL191072A0 (en)	2008-12-29	Therapeutic compositions and methods
GB0601143D0 (en)	2006-03-01	Uses, methods and compositions
EP1962852A4 (en)	2010-07-14	Compounds, compositions and methods
IL190781A0 (en)	2008-11-03	Glp-2 mimetibodies, polypeptides, compositions, methods and uses
PL2215908T3 (en)	2012-03-30	2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
ZA200804502B (en)	2009-10-28	GLP-2 mimetibodies, polypeptides, compositions, methods and uses
IL177759A0 (en)	2007-07-04	Cospeptin, cosmedin and their uses
IL186851A0 (en)	2008-02-09	Styrylsulfonamides, their manufacture and use as pharmaceutical agents
GB0501348D0 (en)	2005-03-02	Compositions and methods
IL186307A0 (en)	2008-01-20	Human glp-1 mimetibodies, compositions, methods and uses
GB0506496D0 (en)	2005-05-04	Compound, composition and use
ZA200608999B (en)	2009-01-28	Human GLP-1 mimetibodies, compositions, methods and uses
GB2444005B (en)	2010-04-07	Compound, composition and use
GB0505203D0 (en)	2005-04-20	Skin composition treatment
GB0517546D0 (en)	2005-10-05	Therapeutic methods and compositions
GB0506495D0 (en)	2005-05-04	Compound, composition and use
GB0515761D0 (en)	2005-09-07	Compound, composition and use